The stock, which dropped 2.8 percent on the day of the report, is currently down 5.6 percent since the release, while the large-cap OMXS30 index has risen by 2.0 percent during the same period.
Based on estimates received after the interim report, Factset's consensus for this year's sales has been lowered by 2.7 percent, while next year's consensus has also been revised down by 2.7 percent.
Consensus for EBITDA results has been reduced by 1.6 percent for this year and by 2.6 percent for next year.
The average recommendation for the stock remains overweight.
The average target price has increased by 0.6 percent to 83.16 kronor, up from 82.63 kronor.
The proportion of positive recommendations now stands at 50 percent (previously 55), while the proportion of hold recommendations is 45 percent (40), and negative recommendations remain at 5 percent (5).
| SSAB | ||||
| Share price development on report day | -2.8% | |||
| Date | 2026-02-13 | 2026-01-27 | Difference | Number of estimates |
| Share price | 73.34 | 77.96 | -5.9% | |
| Average target price | 83.16 | 82.63 | 0.6% | |
| Difference between target and current share price | 13.39% | 5.99% | ||
| Consensus recommendation | Overweight | Overweight | 20 | |
| Proportion of positive recommendations | 50% | 55% | 10 | |
| Proportion of hold recommendations | 45% | 40% | 9 | |
| Proportion of negative recommendations | 5% | 5% | 1 | |
| Sales, current year | 99 463 | 102 173 | -2.7% | 16 |
| Sales, next year | 103 652 | 106 571 | -2.7% | 15 |
| Sales growth, next year | 4.2% | 4.3% | ||
| EBITDA result, current year | 13 227 | 13 436 | -1.6% | 16 |
| EBITDA result, next year | 14 393 | 14 782 | -2.6% | 15 |
| EBITDA growth, next year | 8.8% | 10.0% | ||
| Source: Factset |
